Hatsopoulos John 4
4 · TECOGEN INC. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
Tecogen (TGEN) Director John Hatsopoulos Exercises Options
What Happened
- John Hatsopoulos, a director of Tecogen, exercised stock options (transaction code M) on March 20, 2026. The filing shows he acquired 50,000 shares at $0.88 per share (total $44,000) and on the same date disposed of 50,000 shares at $0.88 per share (total $44,000).
- This is an option exercise (derivative transaction), not an open-market purchase or a grant-based award. The simultaneous acquisition and disposition pattern is commonly seen in cashless exercises or sell-to-cover transactions, though the filing itself does not state the reason.
Key Details
- Transaction date: 2026-03-20; Price per share: $0.88.
- Acquired: 50,000 shares for $44,000 (exercise of stock options).
- Disposed: 50,000 shares for $44,000 (reported as a derivative disposition on the same date).
- Footnotes: F1—Shares acquired pursuant to exercise of Stock Option Agreement dated 9/20/2023; F2—Exercise of Stock Option Agreement dated 9/20/2023.
- Shares owned after the transaction: not specified in the provided filing details.
- Filing date: 2026-03-23 — the Form 4 was filed within the standard reporting window (timely).
Context
- For retail investors: exercises show an insider converting options into shares. When some shares are sold the same day, that often reflects a cashless exercise or sell-to-cover taxes/fees rather than a directional bet on the stock.
- This report involves a director (not a >10% owner disclosure). The filing is informational; it does not explain the insider’s motivation.
Insider Transaction Report
Form 4
TECOGEN INC.TGEN
Hatsopoulos John
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-20$0.88/sh+50,000$44,000→ 1,038,951 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-03-20$0.88/sh−50,000$44,000→ 0 totalExercise: $0.88From: 2024-09-20Exp: 2033-09-20→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Shares acquired pursuant to exercise of Stock Option Agreement dated 9/20/2023
- [F2]Exercise of Stock Option Agreement dated 9/20/2023
Signature
/s/ John N. Hatsopoulos|2026-03-23